Addressing Key Targets in Advanced NSCLC: HER2-, HER3-, and TROP2-Targeted Therapies

Chair, Pasi A. Jänne, MD, PhD, Helena A. Yu, MD, and Edward Garon, MD, MS, discuss NSCLC in this CME/MOC activity titled “Addressing Key Targets in Advanced NSCLC: Evaluating the Latest Evidence and Clinical Opportunities for HER2-, HER3-, and TROP2-Targeted Therapies.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/ZGP865. CME/MOC credit will be available until March 21, 2023.